FDAAdvisorycommittee.com
This article was originally published in The Tan Sheet
Executive Summary
The joint Nonprescription Drugs and Metabolic & Endocrinologic Drugs Advisory Committee meeting on the Rx-to-OTC switch of Merck's Mevacor 20 mg will be webcast live beginning at 8 am on Jan. 13 and 14 from Bethesda, Md. For more information, call 1-800-627-8171...